(Q77095843)
Statements
A pharmacoeconomic comparison of antithymocyte globulin and muromonab CD3 induction therapy in renal transplant recipients (English)
D C Brennan
M A Schnitzler
J D Baty
C S Ceriotti
J A Lowell
S Shenoy
T K Howard